Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A phase III clinical trial of monthly minodronate in the treatment of Chinese postmenopausal women with osteoporosis1 passage
• A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk1 passage
• Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina1 passage